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ABSTRACT
Throat swabs from 61 patients, aged 18–32 years, with non-streptococcal tonsillitis (NST) and 92
healthy controls were examined for the presence of Fusobacterium necrophorum DNA using a novel
TaqMan-based real-time quantitative PCR assay for F. necrophorum subspecies. The assay was based
on the gyrB subunit gene, and detected F. necrophorum DNA in 48% of patients with NST and in
21% of controls (p <0.001). F. necrophorum subsp. funduliforme was the only subspecies found in both
patients and controls. The load of F. necrophorum DNA on swabs from patients with NST was
signiﬁcantly higher than that on swabs from controls (p <0.001). Furthermore, patients with recurrent
NST had a signiﬁcantly higher load of F. necrophorum DNA compared to patients with acute NST
(p 0.04). In addition, 26 patients with tonsillitis and group C streptococci (GCS) had a signiﬁcantly
higher load of F. necrophorum DNA compared to the NST group (p <0.001). It was concluded that
F. necrophorum subsp. funduliforme is present in small numbers as part of the normal human throat
ﬂora, and that F. necrophorum in large quantities may cause tonsillitis, especially recurrent tonsillitis.
In addition, the study suggests that the concomitant presence of GCS may aggravate F. necrophorum
tonsillitis.
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INTRODUCTION
Fusobacterium necrophorum causes Lemierre’s syn-
drome, a rare, life-threatening disease described
in 1936 by Lemierre [1]. F. necrophorum is also
associated strongly with peritonsillar abscess and
has recently been connected with tonsillitis [2–4].
F. necrophorum is traditionally described as form-
ing part of the normal ﬂora of the oropharynx,
gastrointestinal tract and genitourinary tract of
humans, but convincing evidence is lacking [5].
Recent studies using PCR or cloning and sequen-
cing of 16S rRNA genes have failed to detect
F. necrophorum on throat swabs from healthy
controls [2,6].
F. necrophorum is divided into two subspecies:
F. necrophorum subsp. necrophorum and F. necro-
phorum subsp. funduliforme. The necrophorum
subspecies is associated mostly with infections
in domestic mammals, whereas subsp. funduli-
forme infects mainly humans [7,8]. Molecular
techniques, e.g., 16S)23S rRNA intergenic spacer
region sequence analysis, random ampliﬁed poly-
morphic DNA–PCR and ribotyping analysis, have
been developed to discriminate between the two
subspecies [9–12], and real-time PCR analysis
has been shown to have potential for detecting
F. necrophorum [2].
The present study describes the use of a
TaqMan-based real-time quantitative PCR assay,
targeting the gyrB gene, to detect and discriminate
between the two subspecies of F. necrophorum in
the throats of healthy volunteers, and to examine
the possible role of F. necrophorum in non-strep-
tococcal tonsillitis (NST). The possible role of
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group C streptococci (GCS) in F. necrophorum
tonsillitis was also evaluated.
MATERIALS AND METHODS
Sample collection, preparation and culturing
Between June 2005 and January 2006, 146 throat swabs from
patients aged 18–32 years were sent to the microbiologi-
cal laboratory at Viborg Hospital, Viborg, Denmark, for routine
detection of bacterial throat pathogens. A diagnosis of tonsillitis
required the presence of sore throat, inﬂamed tonsils and at
least one of the following: fever; enlarged tender lymphatic
glands on the neck; or elevated C-reactive protein. Acute
tonsillitis was deﬁned as a single episode, whereas recurrent
tonsillitis included recurrent acute episodes, relapses within
1 month, and persistent cases with a duration of >1 month.
Each diagnosis of tonsillitis was discussed with the responsible
clinicians by a single infectious diseases specialist, who was
blinded from the PCR and bacteriological results.
Of the 146 throat swabs, 41 were from febrile patients with
infections other than tonsillitis, patients with other throat
diseases, and healthy individuals who were tested because of
infected family members. In total, 105 throat swabs were from
patients who fulﬁlled the criteria for tonsillitis. Forty cases had
tonsillitis associated with haemolytic streptococci, six with
group A streptococci (GAS), 26 with GCS, four with group F
streptococci, and four with group G streptococci. The majority
of the throat swabs were received from general practitioners.
Most general practitioners in Denmark use rapid immunoas-
say kits to detect GAS, thus indicating that most of the throat
swabs required analysis for pathogenic throat bacteria other
than GAS.
There were 65 patients with NST, four of whom were
patients with conﬁrmed acute mononucleosis and were there-
fore excluded. The remaining 61 patients with NST comprised
39 females and 22 males (median age 25 years), of whom 43
and 18 had acute or recurrent NST, respectively. A control
group consisted of 42 healthy female student nurses and 50
healthy male soldiers, aged 18–32 years (median age 22 years),
who had neither suffered from a sore throat nor received
antibiotic therapy in the preceding 2-week period.
Swabs were transported in Stuart’s Transport Medium
(Statens Serum Institut (SSI), Copenhagen, Denmark) within
24 h of being taken. They were then inoculated on Columbia
agar plates containing sheep blood (Becton Dickinson, Heidel-
berg, Germany) 5% v ⁄v and incubated overnight at 35C in
CO2 5% v ⁄v, and also on plates containing horse blood (SSI)
5% v ⁄v that were incubated at 35C in anaerobic jars
containing an atmosphere of CO2 5%, H2 10%, N2 85% v ⁄v.
Plates were examined after incubation for 1, 2 and 4 days.
Throat swabs were stored for up to 2 days at 4C until
extraction of bacterial DNA.
Bacterial identiﬁcation by culture
Initial identiﬁcation of F. necrophorum was based on colony
morphology, an odour of butyric acid, the presence of a
greenish ﬂuorescence from colonies when irradiated with UV
light, and a characteristic Gram-negative pleomorphic mor-
phology under the microscope, supplemented by susceptibil-
ity to kanamycin and metronidazole on primary inoculated
agar plates. Subsequent b-haemolysis on agar containing horse
blood 5% v ⁄v, resistance to vancomycin and susceptibility to
polymyxin conﬁrmed the identiﬁcation of F. necrophorum [13].
F. necrophorum isolates were not identiﬁed to the subspecies
level by culture. b-Haemolytic streptococci were identiﬁed by
colony and cell morphology, as well by haemolysis on
Columbia agar containing sheep blood 5% v ⁄v. Lanceﬁeld
groups were determined using a Slidex Strepto-Kit (bio-
Me´rieux, Marcy l’Etoile, France) [14].
DNA extraction
Bacterial DNA was isolated by vortexing the swabs in 1 mL of
physiological saline for 1 min and then extracting the nucleic
acid from 200 lL of saline using the Kingﬁsher mL magnetic
particle processor (Thermo Electron Corporation, Waltham,
MA, USA) and a Biosprint 15 DNA Blood Kit (Qiagen,
Westburg, The Netherlands), both according to the manufac-
turers’ instructions. Nucleic acids were eluted in 200 lL of the
elution buffer supplied with the extraction kit, and were then
stored at 4C until use.
Design of primers and probes
A subspecies-speciﬁc real-time quantitative PCR assay was
developed for the purpose of detecting and discriminating
between F. necrophorum subsp. necrophorum and subsp. fun-
duliforme. The assay was based on published gyrB sequences
[15]. A primer pair targeting both subspecies, and two
subspecies-speciﬁc TaqMan probes, were designed by mul-
tiple alignment analysis using the sequence alignment editor
BioEdit, and six gyrB sequences of subsp. necrophorum and
four gyrB sequences of subsp. funduliforme available
in GenBank (http://www.ncbi.nlm.nih.gov) [16,17]. The
potential primers and probes were analysed for the require-
ments imposed by real-time PCR using the PrimerQuest
program (http://scitools.idtdna.com/Primerquest/). Finally,
the chosen primers and probes were analysed for speciﬁcity
against GenBank sequences with the BLAST program pack-
age (http://www.ncbi.nlm.nih.gov/BLAST) [18]. Primer pair
gyrB-forward, 5¢-AGGATTGCATGGAGTAGGAA (positions
27–46), and gyrB-reverse, 5¢-CCTATTTCATTTCGACAATCCA
(positions 332–311), amplify a 306-bp fragment from both
subspecies. The subsp. necrophorum-speciﬁc probe, 5¢-TCTAC-
TTTGGAGGTTGGAGAAACAAC (positions 160–185), was
labelled at the 5¢ end with 6-carboxyﬂuorescein, and at the
3¢ end with Black Hole Quencher 1, whereas the subsp.
funduliforme-speciﬁc probe, 5¢-TCCGCTTTAGAGGCTGGAG-
AAACGAC (positions 160–185), was labelled at the 5¢ end
with hexachloroﬂuorescein and at the 3¢ end with Black
Hole Quencher 2. The assay was carried out in two separate
PCRs.
To verify the results of the gyrB assay at the species level, an
F. necrophorum species-speciﬁc real-time PCR assay, modiﬁed
for TaqMan chemistry, was employed [2]. This assay was based
on the ampliﬁcation of a 277-bp fragment of the RNA polym-
erase b-subunit (rpoB) gene using the primers RPO-forward,
5¢-TCTCTACGTATGCCTCACGGATC(positions171–193), and
RPO-reverse, 5¢-CGATATTCATCCGAGAGGGTCTC (posi-
tions 447–424) [2,12]. The TaqMan probe was designed using
PrimerQuest, yielding RPO-probe, 5¢-TTGCCGGCGGAA
GACATGCCTTTCTTA (positions 167–193). The probe was
labelled at the 5¢ end with 6-carboxyﬂuorescein and at the
3¢ end with Black Hole Quencher 1.
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TaqMan qPCR
The PCRs for both assays were carried out in 25-lL reaction
mixtures containing 12.5 lL of 2 · Brilliant QPCR Master Mix
(Stratagene, La Jolla, CA, USA), 2.5 lL of 100 nM (ﬁnal
concentration) TaqMan probe, 2.5 lL of 300 or 400 nM (ﬁnal
concentrations) forward and reverse primer, for the rpoB and
gyrB assays, respectively, and 5 lL of template DNA. Primers
and probes were synthesised by Proligo (Paris, France).
Thermal cycling on an Mx3000P Real Time PCR System
(Stratagene) comprised 10 min at 95C, followed by 55 cycles
of 30 s at 95C and 60 s at 60C for both assays. All samples
were run in duplicate. DNA extracted from F. necrophorum
subsp. necrophorum ATCC 25286 and subsp. funduliforme
ATCC 51357 served as positive controls and were included
in each PCR run. Sterile water was added to a PCR instead of
template as a negative control. In addition, sterile swabs were
processed as described above and were used as templates in
order to control for contamination in the extraction procedure.
Results were analysed using the Mx3000P software package
(Stratagene).
Assay sensitivity and speciﬁcity
The detection limit of the gyrB assay was determined using
ten-fold serial dilutions of a known concentration (1.5 · 100 to
1.5 · 108 CFU ⁄mL) of F. necrophorum subsp. necrophorum
ATCC 25286 and subsp. funduliforme ATCC 51357 in PCRs as
described above. The species speciﬁcity of the assays was
tested using DNA from a variety of bacteria, including several
strains of both subspecies of F. necrophorum, as well as other
Fusobacterium spp., pharyngeal pathogens and commensal
ﬂora of the pharynx (Table 1).
Quantiﬁcation of bacterial load in positive swabs
Quantiﬁcation of F. necrophorum subsp. funduliforme DNA in
positive swabs was performed by including a ten-fold serial
dilution of known concentrations of F. necrophorum subsp.
funduliforme ATCC 51357 (1.5 · 100 to 1.5 · 108 CFU ⁄mL) in
the gyrB assay analysis.
DNA sequence analysis
PCR products in the gyrB assay from ﬁve human throat swabs
(two controls and three patients with NST), as well as DNA
from four F. necrophorum subsp. necrophorum isolates of veter-
inary origin, were sequenced on a 3130 Genetic Analyzer
(Applied Biosystems, Foster City, CA, USA). Sequencing was
carried out using an ABI Prism Big Dye terminator v.1.1 Ready
Reaction Cycle Sequencing kit (Applied Biosystems) according
to the manufacturer’s instructions. PCR products were
sequenced in both directions using both primers of the gyrB
assay. Sequences were subsequently subjected to a BLAST
search analysis to conﬁrm the source as either F. necrophorum
subsp. necrophorum or F. necrophorum subsp. funduliforme.
Statistics
Differences among groups were examined using the Krus-
kal–Wallis test for multi-group comparison, while the Wilc-
oxon rank sum test was used for two-group comparisons. In
addition, chi-square values and ORs were calculated for the
PCR results between healthy controls and cases of NST, as
well as between cases of NST and patients with GCS
tonsillitis. PCR-negative swabs were given a value of
1 CFU ⁄ swab for statistical purposes. Statistical signiﬁcance
was deﬁned as p <0.05. Statistical analyses were performed
using SPSS for Windows v.13.0 (SPSS Inc., Chicago, IL,
USA).
GenBank accession numbers
F. necrophorum subsp. funduliforme—DQ648009, DQ648010,
DQ648011, DQ648012, and DQ648013; F. necrophorum subsp.
necrophorum—DQ648014, DQ648015, DQ648016, and
DQ648017.
RESULTS
Assay sensitivity
The gyrB assay was linear for both subspecies
over the range 1.5 · 103-1.5 · 108 CFU ⁄ swab
(= CFU ⁄mL), corresponding to a threshold cycle
(CT) ranging from 26.6 to 44.0 and from 26.0 to
43.6 cycles for F. necrophorum subsp. necrophorum
and subsp. funduliforme, respectively. The R2
Table 1. Organisms used to test the species-speciﬁcity of
the gyrB assay
Species Source
Fusobacterium necrophorum subsp. necrophorum ATCC 25286
Fusobacterium necrophorum subsp. funduliforme ATCC 51357
Fusobacterium necrophorum subsp. necrophoruma Veterinary isolates
Fusobacterium necrophorum subsp. funduliformeb Clinical isolates
Fusobacterium varium Clinical isolate
Fusobacterium mortiferum Clinical isolate
Fusobacterium nucleatum subsp. animalis Clinical isolate
Fusobacterium nucleatum subsp. nucleatum Clinical isolate
Fusobacterium nucleatum subsp. fusiforme Clinical isolate
Fusobacterium rusii Clinical isolate
Fusobacterium morteferum Clinical isolate
Streptococcus pneumoniae ATCC 49619
Streptococcus agalacticae Clinical isolate
Streptococcus pyogenes Clinical isolate
Streptococcus salivarius Clinical isolate
Streptococcus anginosus Clinical isolate
Streptococcus vestibularis Clinical isolate
Streptococcus dysgalactiae Clinical isolate
Staphylococcus aureus ATCC 29213
Staphylococcus epidermidis Clinical isolate
Corynebacterium diphtheriae Clinical isolate
Archanobacterium haemolyticum Clinical isolate
Haemophilus inﬂuenzae Clinical isolate
Pseudomonas aeruginosa Clinical isolate
Bordetella pertussis Clinical isolate
Bordetella parapertussis Clinical isolate
Peptostreptococcus anaerobius Clinical isolate
Bacteroides fragilis ATCC 25285
Actinomyces israelii Clinical isolate
Prevotella intermediae Clinical isolate
Neisseria gonorrhoeae Clinical isolate
Yersinia enterocolitica Clinical isolate
Pasteurella haemolytica Clinical isolate
Mycoplasma hominis Clinical isolate
Mycoplasma pneumoniae Clinical isolate
Mycoplasma genitalium Clinical isolate
Mycoplasma salivarium Clinical isolate
aTwenty-three isolates from animals.
bForty isolates.
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values were 0.992 (Y = )3.48X + 55.62) and 0.988
(Y = )3.45X + 55.69) for subsp. funduliforme and
subsp. necrophorum, respectively. The minimum
detection limit of the assays for both subspecies
was between 1.5 · 102 and 1.5 · 103 CFU ⁄ swab
(0.75 and 7.5 CFU ⁄ reaction).
Species speciﬁcity of assay
Both assays ampliﬁed DNA successfully from all
24 isolates of F. necrophorum subsp. necrophorum
and all 41 isolates of subsp. funduliforme tested.
No PCR ampliﬁcation signal was detected when
DNA from other pharyngeal bacterial pathogens,
commensal ﬂora of the pharynx, or other species
of the genus Fusobacterium (Table 1) was used as
template for the assays. The gyrB assay assigned
all isolates of F. necrophorum to the correct sub-
species according to previous typing results (data
not shown).
DNA sequence analysis
The sequences of the ﬁve PCR products ampliﬁed
from throat swabs were almost identical, with
one sequence differing from the other four by
two bases. The four sequences ampliﬁed from
F. necrophorum subsp. necrophorum isolates of vet-
erinary origin were identical. BLAST analysis of
the sequences conﬁrmed the speciﬁcity of the
gyrB assay, with the DNA sequences ampliﬁed
from the throat swabs having the highest similar-
ity with known sequences of F. necrophorum
subsp. funduliforme (AY370669, AY370668,
AY37667 and AY370665), and DNA sequences
ampliﬁed from DNA from veterinary isolates of
subsp. necrophorum having the highest similarity
with known sequences of F. necrophorum subsp.
necrophorum (AY372007, AY370663, AY370662,
AY370666, AY370661 and AY370664).
Throat swab analysis
PCR detected the presence of F. necrophorum
DNA on 29 (48%) of 61 swabs from patients with
NST, and on 19 (21%) of 92 swabs from healthy
controls (Table 2). The gyrB assay identiﬁed all
PCR-positive swabs in both the control and the
NST groups as F. necrophorum subsp. funduliforme.
No conﬂicting results were found between the
two real-time PCR assays.
An overall non-parametric multi-group com-
parison revealed a signiﬁcant difference between
test groups (p <0.001) (Fig. 1a). Furthermore, a
non-parametric two-group analysis revealed a
signiﬁcant difference between healthy controls
and NST patients (p <0.001), and between NST
patients and patients with tonsillitis harbouring
GCS (p <0.001) (Fig. 1a). In addition, there was a
signiﬁcant difference in the number of PCR-
positive swabs from healthy controls and NST
patients (p <0.001, OR 3.9, 95% CI 1.7–7.1), and
from NST patients and patients with GCS tonsil-
litis (p 0.02, OR 3.0, 95% CI 1.1–8.1). No differ-
ences in the load of F. necrophorum DNA were
found between swabs from NST patients and
swabs from patients with streptococci other than
GCS by non-parametric multi-group and non-
parametric two-group analysis (data not shown).
Furthermore, the load of F. necrophorum DNA on
the 41 non-tonsillitis throat swabs, of which 11
were PCR-positive, was equivalent to that of the
healthy controls (data not shown).
When NST was divided into acute NST and
recurrent NST, the load of F. necrophorum DNA
was signiﬁcantly greater for patients with recur-
rent NST compared to acute NST (p 0.04)
(Fig. 1b), but there was no difference in the
number of PCR-positive swabs from acute NST
and recurrent NST patients (p 0.4, OR 1.6,
95% CI 0.5–4.8).
Table 2. Results obtained using
real-time quantitative PCR to iden-
tify Fusobacterium necrophorum
subsp. funduliforme on throat swabs
from healthy controls and patientsHealthy controls
n (%)
Patients
n (%)
Non-tonsillitis
n (%)
Tonsillitis
n (%)
NST
n (%)
Tonsillitis with GCS
n (%)
Total 92 146 41 105 61 26
PCR-positive 19 (21) 65 (45) 11 (27) 54 (51) 29 (48) 19 (73)
Acute tonsillitis 68 43 16
PCR-positive 34 (50) 19 (44) 9 (56)
Recurrent tonsillitis 37 18 10
PCR-positive 20 (54) 10 (56) 10 (100)
NST, non-streptococcal tonsillitis; GCS, group C streptococci.
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Growth of F. necrophorum occurred, by anaer-
obic culture, from two swabs in the NST group
but from none in the control group. In addition,
ﬁve swabs from patients with tonsillitis that
were culture-positive for GCS were also culture-
positive for F. necrophorum. All culture-positive
swabs had higher levels of F. necrophorum DNA
than did swabs from controls. Three of the
excluded swabs from patients with acute mono-
nucleosis were positive for F. necrophorum by
PCR, with one also being positive for F. necro-
phorum by culture.
DISCUSSION
The results of this study conﬁrmed that F. necro-
phorum subsp. funduliforme is part of the normal
ﬂora of the human tonsils. Previous studies have
failed to detect F. necrophorum DNA from the
tonsils of healthy humans [2,6]. Aliyu et al. [2]
used a real-time PCR assay targeting rpoB, and did
not detect F. necrophorum in healthy controls, but
found F. necrophorum in 10% of patients with a
‘sore throat’. Aas et al. [6] did not detect F. necro-
phorum on tonsils from ﬁve individuals aged 23–
55 years by sequencing 16S rRNA genes from the
total sample DNA. It was therefore surprising to
detect F. necrophorumDNA on swabs from healthy
individuals in the present study. However, the
ﬁndings seem to be reliable, as both real-time PCR
assays yielded consistent results, and sequencing
of amplicons from both the control and patient
groups showed homology with F. necrophorum
subsp. funduliforme sequences. F. necrophorum
probably resides in small numbers, mainly in the
crypts of the tonsil in healthy humans, but is
present on the surface of inﬂamed tonsils in higher
numbers. This makes it difﬁcult to detect F. necro-
phorum in healthy individuals if swabs are taken
only from the surface of the tonsils.
The low incidence of F. necrophorum revealed
by culture in the present study was probably a
consequence of the fact that the general anaerobic
agar medium used in Denmark is not very
effective for detecting F. necrophorum. As a result
of this study, all throat swabs in this hospital are
now cultured anaerobically on anaerobic agar
plates supplemented with horse blood 5% v ⁄ v,
nalidixic acid 5.0 mg ⁄L and vancomycin
2.5 mg ⁄L, and F. necrophorum is now isolated
from >15% of throat swabs from tonsillitis
patients aged 18–32 years.
F. necrophorum subsp. funduliforme was the only
subspecies found in both the control and the
patient groups, which is in agreement with the
general assumption and previous ﬁndings that
subsp. funduliforme is the subspecies found in
humans [2,19].
Although the aetiology and pathogenesis of
tonsillitis are complex, and viruses may also play
an important role, the present data indicate that
F. necrophorum subsp. funduliforme causes acute
NST, especially recurrent NST, and may account
for some of the cases of tonsillitis considered
previously to be of viral aetiology. Batty et al. [5]
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Fig. 1. Interpolated bacterial load of Fusobacterium necro-
phorum DNA, expressed as CFU ⁄ swab and cycle threshold
(CT) values in swabs: (a) healthy controls, non-streptococ-
cal tonsillitis (NST), and patients with tonsillitis with
group C streptococci (GCS); (b) acute and recurrent NST.
The dotted line indicates a possible threshold above which
normally insigniﬁcant, sub-clinical numbers (<3 · 106
CFU ⁄ swab) of F. necrophorum can cause infection.
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isolated F. necrophorum more frequently from
patients with persistent ‘sore throat‘ than from
patients with acute tonsillitis.
F. necrophorum is a commensal pathogen
known to cause peritonsillar abscesses as well as
Lemierre’s syndrome, and it therefore seems
plausible that F. necrophorum can also cause
tonsillitis. The trigger for F. necrophorum to
cause tonsillitis, or lead to the development of
peritonsillar abscess or Lemierre’s syndrome,
is unknown, but genetic precursors may be
involved [20]. Further studies are required to
reveal the mechanisms involved in the transition
from a local F. necrophorum infection of the tonsils
to Lemierre’s syndrome.
F. necrophorum rarely penetrates intact mucosal
surfaces. Therefore, interaction with viruses and
other bacteria has been suggested as a precursor
for F. necrophorum infection [21,22]. Epstein–Barr
virus has been suspected to be a predisposing
factor for F. necrophorum infection, especially
Lemierre’s syndrome [23,24]. Epstein–Barr virus
is thought to induce immunosuppression, with a
transient decrease in T-cell-mediated immunity
that may predispose to bacterial infection. In the
present study, three of four cases of acute mono-
nucleosis were PCR-positive for F. necrophorum.
Theremay be a connection between F. necrophorum
infection and acute mononucleosis, but a study
with sufﬁcient samples has yet to be conducted.
An association was found between F. necropho-
rum subsp. funduliforme and GCS in patients with
tonsillitis. Such an association was not found
between F. necrophorum and other Lanceﬁeld
groups of streptococci. However, the sample sizes
for other groups of streptococcal tonsillitis were
small, and results regarding GAS may be biased
because of the frequent use of GAS diagnostic kits
by general practitioners. To our knowledge, the
present study is the ﬁrst to suggest a pathogenic
connection between F. necrophorum and GCS,
although a few examples of co-infections with
F. necrophorum and GCS have been reported
previously [25,26]. Blossom et al. [27] recently
reported a classic case of Lemierre’s syndrome
caused by GCS alone. Although F. necrophorum
was not detected, it might have been overlooked
because of the delayed growth of F. necrophorum
compared to GCS in blood cultures. The present
data suggest a synergic relationship between
F. necrophorum subsp. funduliforme and GCS in
tonsillitis, but further research on this topic is
required. In the meantime, it is suggested that all
patients with signs of bacterial tonsillitis be
examined for F. necrophorum.
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